ZAI LAB LIMITED Increase (Decrease) in Income Taxes Receivable
ZAI LAB LIMITED (ZLAB) reported Increase (Decrease) in Income Taxes Receivable of $2.42 million for the 6-month period ending 2020-06-30, per its 6-K filed 2020-09-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2020-09-11
| Period end | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 12 month | Increase (Decrease) in Income Taxes Receivable 12 month as first filed |
|---|---|---|---|
| 2020-06-30 | $2.42M 6-K · filed 2020-09-11 | ||
| 2019-12-31 | $5.69M 20-F · filed 2020-04-29 | ||
| 2019-06-30 | $3.13M 6-K · filed 2020-09-11 | ||
| 2018-12-31 | $2.98M 20-F · filed 2020-04-29 | $2.98M 20-F · filed 2019-03-29 | |
| 2017-12-31 | $3.69M 20-F · filed 2020-04-29 | $3.69M 20-F · filed 2018-04-30 | |
| 2016-12-31 | $1.38M 20-F · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |